PIK3CA mutational status in tissue and plasma as a prognostic biomarker in HR+/HER2− breast cancer
Article in Cancer Medicine (September 2024)
The most recent citing publication is shown below. View this citation on Dimensions.
Article in Cancer Medicine (September 2024)